Abstract
The availability of tritium labeled cyproterone acetate (CPA) facilitated the systematic investigation of the binding characteristics of this compound for human uterine progesterone receptors (PgR). The binding parameters of 3H-CPA are compared to those of 3H-R5020 and 3H-progesterone. The rate constants of association (k1M-1sec-1) to PgR were 7.8 x 103 for 3H-R5020, 4.5 x 104 for 3H-progesterone and 4.0 x 104 for 3H-CPA. The rate constants of dissociation (k-1, sec-1) were 3.6 x 10-5 for 3H-R5020, 21.3 x 10-5 for 3H-progesterone and 17.8 x 10-5 for 3H-CPA. The Kd-values (M), as obtained by titration analysis and subsequent Scatchard plot analysis were 1.2 x 10-9 for 3H-R5020, 6.0 x 10-9 for 3H-progesterone and 5.2 x 10-9 for 3H-CPA. On sucrose density gradient analysis binding in the 3.5, 5 and 8 S area could be observed using 3H-R5020. For 3H-progesterone and 3H-CPA binding was exclusively found in the 5 S area. The specificity of the steroid binding site of PgR is identical for 3H-R5020 and 3H-CPA. The order of potency of binding for various competitors decreases identically for both radioactive ligands: R5020 < progesterone < R1881< CPA < dihydrotestosterone < dexamethasone < cyproterone < 15β-OH-cyproterone. CPA resembles progesterone very closely in its binding characteristics to human uterine PgR.
Similar content being viewed by others
References
Wiechert R., Steinbeck H., Elger W., Neumann F. Wirkungen und Struktur neuer antiandrogener Steroide. Arzneirh. Forsch. 17: 1103, 1967.
Bruchovsky N. Molekulare Wirkung von Androgenen unt Antiandrogenen. In: Hammerstein J., Lachnit-Fixon U., Neumann F., Plewig G. (Eds.), Androgenisierungserscheinungen bei der Frau. Excerpta Medica, Amsterdam, Oxford, Princeton, 1979, p. 7.
Mainwaring W.I.P. Modes of action of antiandrogens: a survey. In: Martini L, Motta M. (Eds.), Androgens and antiandrogens. Raven Press, New York, 1977, p. 151.
Neumann F., Elger W., Nishino Y., Steinbeck H. Probleme der Dosinfindung — Sexualhormone. Arzneim. Forsch. 27: 296, 1977.
Smith R.B., Walsh P.C., Goodwin W.E. Cyproterone acetate in the treatment of advanced carcinoma of the prostate. J. Urol. 110: 106, 1973.
Wein A.J., Murphy J.J. Experience in the treatment of prostatic carcinoma with cyproterone acetate. J. Urol. 109: 68, 1973.
Horn H.J. Administration of antiandrogens in hypersexuality and sexual deviations. In: Eichler O., Farah A., Herken H., Welch A.D. (Eds.), Handbook of experimental pharmacology. Springer-Verlag, Berlin, Heidelberg, New York, Band 35/2, 1974, p. 543.
Laschet U., Laschet L. Psychopharmacotherapy of sex offenders with cyproterone acetate. Pharmakopsychiatr. Neuropsychopharmakol. 4: 99, 1971.
Neumann F., Diallo F.A., Hsan S.H., Schenck V., Traore I. The influence of pharmaceutical compounds on male fertility. Andrologia 8: 203, 1976.
Roy S., Chatterjee S., Prasad M.R.N., Poddar A.K., Pandey D.C. Effects of cyproterone acetate on reproductive functions in normal human males. Contraception 14: 403, 1976.
Beyer J., Demisch K., Wiegelmann W., Happ J., Kol-Imann F., Schöffling K. Cyproterone acetate in the treatment of infantile andro-genital syndrome with precocious puberty. Acta Endocrinol. (Kbh.) (Suppl.) 173: 169, 1973.
Rager K., Huenges R., Gupta D., Bierich J. The treatment of precocious puberty with cyproterone acetate. Acta Endocrinol. (Kbh.) 74: 399, 1973.
Wiechert R., Neumann F. Gestagene Wirksamkeit von 1 -Methyl- und 1, 2 -Methy-len-Steroiden. Arzneim. Forsch. 15: 244, 1965.
Neumann F. The physiological action of progesterone and the pharmacological effects of progesterone — a short review. Postgrad. Med. J. 54 (Suppl. 2): 11, 1978.
Plewig G., Luderschmidt S. Wirkung von Antiandrogen auf Talgdrüsen und Acne vulgaris. Tieruntersuchungen und Untersuchungen an Aknepatienten. In: Hammerstein J., Lachnit-Fixson V., Neumann F., Plewig G. (Eds.), Androgenisierungserscheinungen bei der Frau. Excerpta Medica, Amsterdam, Oxford, Princeton, 1979, p. 83.
Zaun H. Hirsutismus und androgentische Alopezie. Klinik und Diagnostik. In: Hammerstein J., Lachnit-Fixson V., Neumann F., Plewig G. (Eds.), Androgenisierungserscheinungen bei der Frau. Excerpta Medica, Amsterdam, Oxford, Princeton, 1979, p. 88.
Schenck V., Neumann F. Influence of antiandrogens on Sertoli cell function and intratesticular androgen transport. Intern. J. Androl. 7: 459, 1978.
Neumann F., Elger W., Nishino Y., Steinbeck H. Probleme der Dosisfindung: Sexualhormone. Drug Res. 27: 296, 1977.
Viguier-Martinez M.C., Hocherau-DeReviers M.T. Comparative action of cyproterone and cyproterone acetate on pituitary and plasma gonadotropin levels, the male genital tract and spermatogenesis in the growing rat. Ann. Biol. Anim. Biochim. Biophys. 17: 1069, 1977.
Beier S., Haase F., Kosub V., Dusterberg V., Elger W. The progestational activity of different gestagens used for human contraception in the beagle bitch. Contraception 20: 533, 1979.
Elger W. Einflu β von Gestagenen auf Befruchtung, Eiernährung, Eitransport und Schwangerschaftsverlauf. In: Gunkmann K. (Ed.), Handbuch der experimentellen Pharmakologie. Springer-Verlag, Berlin, Heidelberg, New York, Band XXII, 1969, p. 132.
Scatchard D.G. The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51: 660, 1949.
Waddell W.J. A simple ultraviolett spectrophotometric method for the determination of proteins. J. Lab. Clin. Med. 48: 311, 1956.
Price N.C., Dwek R.A. Principles and problems in physical chemistry for biochemists. Clarendon Press, Oxford, 1974.
Korenman S.G. Relation between estrogen inhibitory activity and binding to cytosol of rabbit and human uterus. Endocrinology 87: 1119, 1970.
Neumann F., Schenck B. New antiandrogens and their mode of action. J. Reprod. Fertil. (Suppl.) 24: 129, 1976.
Philibert D., Ojasso T., Raynaud J.P. Properties of the cytoplasmic progestin-binding protein in the rabbit uterus. Endocrinology 101: 1850, 1977.
Terenius L. Affinities of progestogen and estrogen receptors in rabbit uterus for synthetic progestogens. Steroids 23: 909, 1974.
Wakeling A.E., Furr B.J.A., Glen A.T., Hughes L.R. Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens. J. Steroid Biochem. 15: 355, 1981.
Neumann F. Pharmakologie der Antiandrogene. In: Hammerstein J., Lachnit-Fixson V., Neumann F., Plewig G. (Eds.), Androgenisierungserscheinungen der Frau. Excerpta Medica, Amsterdam, Oxford, Princeton, 1979, p. 149.
Bhargava A.S., Soeger A., Gunzel P. Isolation and identification of 15β-hydroxy cyproterone acetate as a new metabolite in dog, monkey and man. Steroids 30: 407, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grill, H.J., Manz, B., Elger, W. et al. 3H-cyproterone acetate: binding characteristics to human uterine progestagen receptors. J Endocrinol Invest 8, 135–141 (1985). https://doi.org/10.1007/BF03350668
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350668